WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD DisclosureItem 7.01Regulation FD Disclosure.
On May 24, 2018, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing that its Management Team will present an overview of the Company’s business at the following investor conferences:
|
Jefferies 2018 Global Healthcare Conference in New York, New York at 8:00 a.m. EDT on Tuesday, June 5, 2018; and |
|
Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California at 10:00 a.m. PDT on Thursday, June 14, 2018. |
A copy of the press release issued by the Company is attached hereto as Exhibit 99.1 and incorporated herein by reference.
A copy of the Company’s presentation materials from the conferences will be available through the Investors link at the Company’s website, http://www.westpharma.com.
The information in this report (including Exhibit 99.1) is being furnished to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.
Item 9.01Financial Statements and Exhibits.
|
(d) |
Exhibit No. |
Description |
|
99.1 |
West Pharmaceutical Services, Inc. Press Release, dated May 24, 2018. |
WEST PHARMACEUTICAL SERVICES INC ExhibitEX-99.1 2 exh991may242018pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Investor Contact:Media Contact:Quintin LaiEmily DenneyVice President,…To view the full exhibit click here
About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.
